Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avicanna (DE:0NN)
FRANKFURT:0NN
Avicanna (0NN) Stock Price & Analysis
0 Followers
0NN Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.16 - €0.38
Previous Close€0.23
Volume0.00
Average Volume (3M)547.00
Market Cap
€23.16M
Enterprise Value€26.77M
Total Cash (Recent Filing)C$718.29K
Total Debt (Recent Filing)C$2.13M
Price to Earnings (P/E)N/A
Beta1.06
Next Earnings
Aug 12, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding97,913,896
10 Day Avg. Volume55
30 Day Avg. Volume547
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)-54.34
Price to Sales (P/S)5.95
Price to Cash Flow (P/CF)N/A
P/FCF Ratio97.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Avicanna News
PremiumCompany Announcements
Avicanna Hits Record Earnings and Expands Globally
PremiumCompany Announcements
Avicanna’s CBD Cream Shows Promise for EB Treatment
PremiumCompany Announcements
Avicanna Secures Funding to Fuel Growth
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
0NN FAQ
What was Avicanna’s price range in the past 12 months?
Avicanna lowest stock price was €0.16 and its highest was €0.38 in the past 12 months.
What is Avicanna’s market cap?
Currently, no data Available
When is Avicanna’s upcoming earnings report date?
Avicanna’s upcoming earnings report date is Aug 12, 2024 which is in 87 days.
How were Avicanna’s earnings last quarter?
Currently, no data Available
Is Avicanna overvalued?
According to Wall Street analysts Avicanna’s price is currently Overvalued.
Does Avicanna pay dividends?
Avicanna does not currently pay dividends.
What is Avicanna’s EPS estimate?
Avicanna’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Avicanna have?
Currently, no data Available
What happened to Avicanna’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Avicanna?
Currently, no hedge funds are holding shares in DE:0NN
---
Avicanna Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth $51.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.70%
12-Months-Change
Fundamentals
Return on Equity
-1892.45%
Trailing 12-Months
Asset Growth
20.66%
Trailing 12-Months
Company Description
Avicanna
Avicanna is an Ontario corporation focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products via its two main business segments, cultivation and R&D With two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia are the base for Avicanna's cultivation activities. These companies are licensed to cultivate and process cannabis for the production of cannabis extracts and purified cannabinoids including CBD and THC. Avicanna's research and development business is primarily conducted out of Canada at its headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto. Avicanna has engaged the services of researchers at the Leslie Dan Faculty of Pharmacy at the University of Toronto.
---
0NN Earnings Call
Q4 2024
0:00 / 0:00
---
Technical Analysis
---